ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $0

      Shares

      0

      % of Portfolio

      0.00%

      Average Buy Price

      $16.7

      Avg closing price
      Price range

      6 Cathie Wood Rubius Therapeutics Trades

      Cathie Wood started to build up the position in Rubius Therapeutics in Q3 2018 and continued to invest until Q4 2019. Since then they sold 681k shares. The investor completely sold their stake between Q1 2020 and Q2 2020.

      Avg closing price
      Price range
      Sold -318k shares Q2 2020
      Avg closing price $5.90
      Price range $4.01 - $6.88
      Sold 53.3% shares (-363k shares) Q1 2020
      Avg closing price $7.43
      Price range $3.74 - $9.84
      Increased shares by 28.5% (+151k shares) Q4 2019
      Avg closing price $9.67
      Price range $7.23 - $14.12
      Increased shares by 68.1% (+214k shares) Q1 2019
      Avg closing price $15.35
      Price range $13.27 - $18.51
      Increased shares by 67.4% (+127k shares) Q4 2018
      Avg closing price $18.23
      Price range $13.83 - $22.97
      New holding (+188k shares) Q3 2018
      Avg closing price $22.86
      Price range $20.06 - $26.94

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×